http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-631964-A5
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14effe3850d2129f863b969dac4f1db8 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D303-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-24 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-16 |
filingDate | 1977-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddfe6127e5883ad6e99505999f413ddf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_079723942e37c6bab4a2c3a303ee1018 |
publicationDate | 1982-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CH-631964-A5 |
titleOfInvention | Process for preparing esters of 4-alkylaminobenzoic acids |
abstract | The novel esters correspond to the formula: <IMAGE> or <IMAGE> in which R4 represents an alkyl group CnH2n+1 having n = 8 to 19 and the other symbols have the meanings given in Claim 1. They are prepared by alkylating corresponding esters of 4-aminobenzoic acid at 50 to 150 DEG C with an alkylating agent yielding R4. The esters (I and I') lower the serum content of sterols and triglycerides and inhibit the development of atheromatous damage; they are more readily absorbed from the gastrointestinal tract than are the carboxylic acids and other esters. They are used for treating atherosclerosis. |
priorityDate | 1977-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 105.